Evolution of homocysteine during ovarian stimulation for IVF or ICSI.

By Bettahar-Lebugle K.   Feugeas O.   Wittemer C.   Ohl J.   Rongieres C.   Nisand I.  

Gynecology Obstetrique & Fertilite, Vol. 30, Iss. 2, 2002-02 ,pp. : 121-128

Elsevier

Access to resources Recommend Favorite

Comparison of GnRH agonists and antagonists in unselected IVF/ICSI patients treated with different controlled ovarian hyperstimulation protocols: a matched study

By Del Gadillo J.C.B.   Siebzehnrubl E.   Dittrich R.   Wildt L.   Lang N.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 102, Iss. 2, 2002-05 ,pp. : 179-183

Elsevier

Access to resources Recommend Favorite

GnRH Antagonist Improved Blastocyst Quality and Pregnancy Outcome After Multiple Failures of IVF/ICSI–ET with a GnRH Agonist Protocol

By Takahashi Katsuhiko   Mukaida Tetsunori   Tomiyama Tatsuhiro   Goto Tetsuya   Oka Chikahiro  

Journal of Assisted Reproduction and Genetics, Vol. 21, Iss. 9, 2004-09 ,pp. : 317-322

Springer Publishing Company

Access to resources Recommend Favorite

The Practical Implications of a Raised Serum FSH and Age on the Risk of IVF Treatment Cancellation Due to a Poor Ovarian Response

By Akande Valentine A.   Keay Stephen D.   Hunt Linda P.   Mathur Rajneesh S.   Jenkins Julian M.   Cahill David J.  

Journal of Assisted Reproduction and Genetics, Vol. 21, Iss. 7, 2004-07 ,pp. : 257-262

Springer Publishing Company

Access to resources Recommend Favorite

What should be the maximum FSH dose in IVF/ICSI in poor responders?

By Siristatidis C. S.   Hamilton M. P.  

Journal of Obstetrics & Gynaecology, Vol. 27, Iss. 4, 2007-01 ,pp. : 401-405

Informa Healthcare

Access to resources Recommend Favorite